Doctor profile · Federal record
Dr. Marc Warmuth, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · St Augustine, FL
- NPI 1265429989
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 35 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
121 Whitehall Dr
St Augustine, FL 320865266
(904) 825-4500
fax (904) 825-3672 - Additional location
-
2 Shircliff Way
Jacksonville, FL 322044753
(904) 388-2619
fax (904) 388-0240 - Mailing address
-
7751 Belfort Pkwy Ste 350
Jacksonville, FL 322566951
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- August 27, 2025
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Florida #ME 73421
- Medicaid
- FL #255201900
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1265429989. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
152,587
Distinct HCPCS
10
Medicare allowed
$1,990,551
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 51,950 | 317 | $0 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 37,500 | 27 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 17,400 | 23 | $54 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 10,960 | 13 | $0 | |
J1453 |
Injection, fosaprepitant, 1 mg | 9,150 | 27 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 3,480 | 30 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 3,420 | 69 | $0 | |
A9575 |
Injection, gadoterate meglumine, 0.1 ml | 2,275 | 105 | $0 | |
Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 1,990 | 19 | $8 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,984 | 652 | $8 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 2,384. This provider delivers 64× the peer median.Open Payments
Industry payments received
All-time total
$221
Transactions
12
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $50.00 | |
| Genentech USA, Inc. | 2 | $26.81 | |
| Incyte Corporation | 1 | $20.05 | |
| Janssen Biotech, Inc. | 1 | $19.83 | |
| GENZYME CORPORATION | 1 | $16.76 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15.37 | |
| Agios Pharmaceuticals, Inc. | 1 | $14.66 | |
| Novartis Pharmaceuticals Corporation | 1 | $14.64 | |
| AstraZeneca Pharmaceuticals LP | 1 | $14.57 | |
| Ipsen Biopharmaceuticals, Inc | 1 | $14.20 | |
| Merck Sharp & Dohme LLC | 1 | $13.79 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,110
Patients
327
Total drug cost
$755,769
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 196 | 56 | $5,519 |
| Ondansetron Hcl | Generic | 114 | 49 | $1,300 |
| Dexamethasone | Generic | 99 | 27 | $1,851 |
| Letrozole | Generic | 97 | 21 | $2,160 |
| Prednisone | Generic | 82 | 21 | $551 |
| Eliquis (Apixaban) | Brand | 75 | 19 | $63,927 |
| Gabapentin | Generic | 72 | 21 | $987 |
| Hydroxyurea | Generic | 58 | 17 | $2,101 |
| Prochlorperazine Maleate | Generic | 57 | 36 | $2,052 |
| Lorazepam | Generic | 54 | 18 | $177 |
Frequently asked questions
What is Dr. Marc Warmuth's medical specialty?
Dr. Marc Warmuth practices Hematology & Oncology Physician in St Augustine, FL.
Where does Dr. Marc Warmuth practice?
Dr. Marc Warmuth practices at 121 Whitehall Dr, St Augustine, FL 320865266. Office phone: 9048254500.
What is Dr. Marc Warmuth's NPI?
Dr. Marc Warmuth's National Provider Identifier (NPI) is 1265429989, issued by NPPES.
Does Dr. Marc Warmuth accept Medicare assignment?
Yes. Dr. Marc Warmuth accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Marc Warmuth commonly perform?
Top Medicare-reported procedures in 2023: Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS Q9967); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.